Exploring how iron deficiency anemia affects child development in young children
Official title: Study on the Association Between Iron Deficiency Anemia and Neurobehavioral Development and Cognitive Function in Children Aged 6 to 24 Months
Run by Pingshan District Maternal & Child Healthcare Hospital of Shenzhen · NCT06662045 · Data updated 2026-11-12
This study looks at how iron deficiency anemia affects the development of young children between 6 to 24 months old, focusing on their motor skills, language, and social behavior.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Months to 6 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Pingshan District Maternal & Child Healthcare Hospital of Shenzhen Academic / other |
| Locations | 1 site (Shenzhen, China/Guangdong) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | October 28, 2024 |
| Trial ID | NCT06662045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6 to 24 months diagnosed with iron deficiency anemia or confirmed non-anemic status.
✕Probably not a fit
Patients with congenital or chronic illnesses affecting neurodevelopment, or those with recent severe infections or trauma, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the impact of iron deficiency anemia on neurobehavioral and cognitive development in children aged 6 to 24 months. Conducted in pediatric health clinics in Pingshan District, Shenzhen, China, the study will assess children through blood tests to determine anemia status and evaluate their neurodevelopment using a standardized scale. The research aims to understand how anemia influences motor skills, language ability, social behavior, and overall growth metrics such as weight and height.
Why it matters
Potential benefit: If successful, this study could provide insights into the importance of addressing iron deficiency anemia to improve developmental outcomes in young children.
How similar studies have gone: Other studies have shown a correlation between iron deficiency and developmental delays, suggesting that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 6 to 24 months at the time of enrollment * Diagnosed with iron-deficiency anemia (for the exposure group) or confirmed * non-anemic status (for the control group) based on blood test results * Resident in the study area for at least 6 months prior to enrollment * Availability of parental or guardian consent to participate in the study and willingness to follow study protocols * Completion of all baseline assessments, including neurodevelopmental and physical growth evaluations Exclusion Criteria: * Presence of congenital or chronic illnesses that could affect * neurodevelopment, such as Down syndrome or cerebral palsy. * History of severe infections or trauma within 3 months prior to enrollment that * could influence neurodevelopmental outcomes * Current use of medications or treatments that may interfere with iron metabolism (e.g., iron supplementation or blood transfusions in the last 6 months) * Premature birth (before 37 weeks of gestation) or low birth weight (\< 2,500 grams) * Parental refusal to provide consent or non-compliance with study procedures.
Where it's running
-
Shenzhen Pingshan District Maternity & Child Healthcare Hospital, Department of Child Healthcare
Shenzhen, China/Guangdong, China Recruiting
Study contacts
- Study coordinator: Moujinsong Project Manager, M.Sc
- Email: 582260375@qq.com
- Phone: +86 075528799171
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Preconception versus early-pregnancy iron screening and treatment
This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.
-
Ferric derisomaltose injection in adults with iron deficiency anemia under fasting conditions
This study tests whether a ferric derisomaltose injection given to adults with iron deficiency anemia in a fasting state works similarly to a reference product and is safe to use.
-
FACE-APPS approach to improve iron in adolescent girls in marginalized communities
This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.
-
Acupoint TENS vs. Resistance Training for Iron Deficiency Anemia in Women
This trial tests whether acupoint transcutaneous electrical nerve stimulation (Acu-TENS) or resistance exercise, in addition to standard care, can raise hemoglobin levels in women with iron deficiency anemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.